People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Onconetix, Inc. | — | Biotechnology | Series A | $22.0M | $37.7M | 2025 |
Andrew Oakley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew Oakley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Sapirstein | 1 | 7 |
| Ajit Singh | 1 | 5 |
| Karina Fedasz | 1 | 2 |
| Thomas Meier | 1 | 1 |
| Ralph Schiess | 1 | 1 |
| Joseph Hernandez | 1 | 1 |
| Simon Tarsh | 1 | 1 |
| Timothy Ramdeen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.